744 related articles for article (PubMed ID: 9219858)
1. Proconvulsive effect of vasopressin; mediation by a putative V2 receptor subtype in the central nervous system.
Croiset G; De Wied D
Brain Res; 1997 Jun; 759(1):18-23. PubMed ID: 9219858
[TBL] [Abstract][Full Text] [Related]
2. C-terminal deletions in agonistic and antagonistic analogues of vasopressin that improve their specificities for antidiuretic (V2) and vasopressor (V1) receptors.
Manning M; Misicka A; Olma A; Klis WA; Bankowski K; Nawrocka E; Kruszynski M; Kolodziejczyk A; Cheng LL; Seto J
J Med Chem; 1987 Dec; 30(12):2245-52. PubMed ID: 2960812
[TBL] [Abstract][Full Text] [Related]
3. V2-like vasopressin receptor mobilizes intracellular Ca2+ in rat medullary collecting tubules.
Champigneulle A; Siga E; Vassent G; Imbert-Teboul M
Am J Physiol; 1993 Jul; 265(1 Pt 2):F35-45. PubMed ID: 8342613
[TBL] [Abstract][Full Text] [Related]
4. [Arg8]vasotocin excites neurones in the dorsal vagal complex in vitro: evidence for an action through novel class(es) of CNS receptors.
Ingram CD; Tolchard S
J Neuroendocrinol; 1994 Aug; 6(4):415-22. PubMed ID: 7987372
[TBL] [Abstract][Full Text] [Related]
5. Solid-phase synthesis of 16 potent (selective and nonselective) in vivo antagonists of oxytocin.
Manning M; Kruszynski M; Bankowski K; Olma A; Lammek B; Cheng LL; Klis WA; Seto J; Haldar J; Sawyer WH
J Med Chem; 1989 Feb; 32(2):382-91. PubMed ID: 2913298
[TBL] [Abstract][Full Text] [Related]
6. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
[TBL] [Abstract][Full Text] [Related]
7. A V1-type receptor for mediating the neurohypophysial hormone-induced ACTH release in trout pituitary.
Pierson PM; Guibbolini ME; Lahlou B
J Endocrinol; 1996 Apr; 149(1):109-15. PubMed ID: 8676042
[TBL] [Abstract][Full Text] [Related]
8. Effects of a D-Cys6/L-Cys6 interchange in nonselective and selective vasopressin and oxytocin antagonists.
Manning M; Cheng LL; Klis WA; Balaspiri L; Olma A; Sawyer WH; Wo NC; Chan WY
J Med Chem; 1995 May; 38(10):1762-9. PubMed ID: 7752199
[TBL] [Abstract][Full Text] [Related]
9. Vasopressin-induced calcium signaling in cultured hippocampal neurons.
Brinton RD; Gonzalez TM; Cheung WS
Brain Res; 1994 Oct; 661(1-2):274-82. PubMed ID: 7834378
[TBL] [Abstract][Full Text] [Related]
10. Discovery and design of novel and selective vasopressin and oxytocin agonists and antagonists: the role of bioassays.
Chan WY; Wo NC; Stoev ST; Cheng LL; Manning M
Exp Physiol; 2000 Mar; 85 Spec No():7S-18S. PubMed ID: 10795902
[TBL] [Abstract][Full Text] [Related]
11. Vasopressin-induced sensitization: involvement of neurohypophyseal peptide receptors.
Poulin P; Szot P; Dorsa DM; Pittman QJ
Eur J Pharmacol; 1995 Dec; 294(1):29-39. PubMed ID: 8788413
[TBL] [Abstract][Full Text] [Related]
12. Enhanced renal vasoconstriction induced by vasopressin in SHR is mediated by V1 receptors.
Feng JJ; Arendshorst WJ
Am J Physiol; 1996 Aug; 271(2 Pt 2):F304-13. PubMed ID: 8770161
[TBL] [Abstract][Full Text] [Related]
13. V2 receptor antagonism of DDAVP-induced release of hemostasis factors in conscious dogs.
Bernat A; Hoffmann P; Dumas A; Serradeil-le Gal C; Raufaste D; Herbert JM
J Pharmacol Exp Ther; 1997 Aug; 282(2):597-602. PubMed ID: 9262320
[TBL] [Abstract][Full Text] [Related]
14. Vasopressin and oxytocin receptors on plasma membranes from rat mammary gland. Demonstration of vasopressin receptors by stimulation of inositol phosphate formation, and oxytocin receptors by binding of a specific 125I-labeled oxytocin antagonist, d(CH2)5(1)[Tyr(Me)2, Thr4,Tyr-NH2(9)]OVT.
Soloff MS; Fernström MA; Fernström MJ
Biochem Cell Biol; 1989; 67(2-3):152-62. PubMed ID: 2546575
[TBL] [Abstract][Full Text] [Related]
15. [Arg8]-vasopressin-induced increase in intracellular Ca2+ concentration in cultured rat hippocampal neurons.
Mihara T; Tarumi T; Sugimoto Y; Chen Z; Kamei C
Brain Res Bull; 1999 Jul; 49(5):343-7. PubMed ID: 10452354
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of arginine vasotocin vascular smooth muscle receptors in the trout (Oncorhynchus mykiss) in vitro.
Conklin DJ; Smith MP; Olson KR
Gen Comp Endocrinol; 1999 Apr; 114(1):36-46. PubMed ID: 10094857
[TBL] [Abstract][Full Text] [Related]
17. Endothelium-dependent relaxation of human saphenous veins in response to vasopressin and desmopressin.
Aldasoro M; Medina P; Vila JM; Otero E; Martinez-León JB; Lluch S
J Vasc Surg; 1997 Apr; 25(4):696-703. PubMed ID: 9129626
[TBL] [Abstract][Full Text] [Related]
18. Vasopressin and oxytocin receptors coupled to Ca2+ mobilization in rat inner medullary collecting duct.
Maeda Y; Han JS; Gibson CC; Knepper MA
Am J Physiol; 1993 Jul; 265(1 Pt 2):F15-25. PubMed ID: 8393622
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of V1a vasopressin receptors in the rat cortical collecting duct.
Ammar A; Roseau S; Butlen D
Am J Physiol; 1992 Apr; 262(4 Pt 2):F546-53. PubMed ID: 1533099
[TBL] [Abstract][Full Text] [Related]
20. The effects of [Arg8]vasopressin and [Arg8]vasotocin on the firing rate of suprachiasmatic neurons in vitro.
Mihai R; Coculescu M; Wakerley JB; Ingram CD
Neuroscience; 1994 Oct; 62(3):783-92. PubMed ID: 7870306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
